Transmission and prevention: latest news

Transmission and prevention resources

  • Transmission and viral load

    An undetectable viral load shows that HIV treatment is working well and that there is very little HIV in body fluids.In this situation, the risk...

    From: The basics

    Information level Level 1
  • How to get PrEP in the UK

    NHS services in the UK cannot currently provide PrEP.But it is legal to buy PrEP drugs online and import them for your personal use.To use PrEP safely, you...

    From: Factsheets

    Information level Level 2
  • Pre-exposure prophylaxis (PrEP)

    PrEP is highly effective in preventing the sexual transmission of HIV. For PrEP to work well, it’s important to take the pills regularly.While PrEP can...

    From: Factsheets

    Information level Level 2
  • Post-exposure prophylaxis (PEP)

    PEP involves taking a 28-day course of anti-HIV drugs, after possible exposure to HIV.Doctors will assess your risk of HIV infection before prescribing PrEP.PEP is available from...

    From: Factsheets

    Information level Level 2
  • HIV and having a baby

    Women living with HIV can give birth without passing on HIV to the baby.Your options for conception will depend on your health and your partner’s...

    From: Factsheets

    Information level Level 2
  • HIV transmission

    The two main ways in which HIV is passed on are unprotected vaginal and anal sex.Condoms, PrEP and HIV treatment are effective ways of preventing...

    From: Factsheets

    Information level Level 2
  • Viral load and transmission – a factsheet for HIV-negative people

    People with HIV who are on treatment and have an undetectable viral load are extremely unlikely to pass on HIV.Large scientific studies have proven this.Not...

    From: Factsheets

    Information level Level 2
  • Viral load and transmission – a factsheet for people with HIV

    Effective HIV treatment reduces the amount of HIV in your body fluids.Having an undetectable viral load greatly reduces your chance of passing HIV on to...

    From: Factsheets

    Information level Level 2
  • PrEP

    This briefing paper provides an overview of pre-exposure prophylaxis (PrEP) for people planning, commissioning or providing HIV prevention activities in the UK. It does this by reviewing...

    From: HIV prevention briefing papers

  • Sex and HIV

    Sex, desire and pleasure need not stop when you have an HIV diagnosis. Women continue to be sexually active and to have fulfilling sexual and emotional relationships. Many...

    From: Booklets

    Information level Level 2
  • Sex

    Having HIV can affect people’s feelings about sex in many different ways. Some people become anxious about passing HIV on, or feel less desirable. While some people go...

    From: Booklets

    Information level Level 2
  • Transmission of drug-resistant virus

    Some people contract HIV that is already resistant to one or more anti-HIV drugs (this has been the case for between 6 and 10% of people in...

    From: Booklets

    Information level Level 2
  • HIV treatment as prevention

    This briefing paper, produced by NAM for HIV Prevention England, describes the scientific evidence for HIV treatment as prevention and considers its implications for the UK....

    From: HIV prevention briefing papers

  • Undiagnosed HIV infection

    This briefing paper, produced by NAM for HIV Prevention England, covers undiagnosed HIV infection and late diagnosis of HIV in the UK....

    From: HIV prevention briefing papers

  • Oral sex

    Many people enjoy giving and receiving oral sex – kissing, licking or sucking another person’s genitals.The risk of getting HIV from performing oral sex on someone with HIV...

    From: Factsheets

    Information level Level 2
  • Bacterial vaginosis

    Bacterial vaginosis may occur when the balance of bacteria in the vagina becomes disrupted. Symptoms include changes to vaginal discharge and a fishy smell.Having bacterial vaginosis increases the risk...

    From: Factsheets

    Information level Level 2
  • Behaviour change

    A practical introduction to the evidence regarding the effectiveness of non-biomedical HIV prevention methods....

    From: Preventing HIV

    Information level Level 4
  • Post-exposure prophylaxis

    Post-exposure prophylaxis (PEP) has been in use, in healthcare settings, since 1988. Providing PEP after sexual exposure is more controversial....

    From: Preventing HIV

    Information level Level 4
  • Pre-exposure prophylaxis

    Pre-exposure prophylaxis is an experimental HIV-prevention strategy that would use antiretrovirals (ARVs) to protect HIV-negative people from HIV infection....

    From: Preventing HIV

    Information level Level 4
  • Microbicides

    Microbicides are any substances which protect people against infection by microbes, such as viruses or bacteria, on contact with those microbes....

    From: Preventing HIV

    Information level Level 4
  • Preventing HIV

    An essential resource providing evidence-based information on preventing HIV infection. ...

    From: Aidsmap 2.0

    Information level Level 4
  • Risk

    An examination of prosecuted behaviours, using scientific evidence to determine actual risk, and how this evidence has been applied in jurisdictions worldwide....

    From: HIV & the criminal law

    Information level Level 4
  • HIV transmission & testing

    A practical guide to the complexities surrounding HIV transmission routes, risks and HIV testing. ...

    From: Aidsmap 2.0

    Information level Level 4

Transmission and prevention features

Transmission and prevention in your own words

  • Bored and horny

    It’s Sunday afternoon and it’s raining. I’m bored and horny. However, I’ve got £20 left over from the night before and this will be enough...

    From: In your own words

Transmission and prevention news from aidsmap

More news

Transmission and prevention news selected from other sources

  • London-wide HIV prevention programme to face 10% budget cuts

    The programme is due to expire in March 2017 - council leaders were asked to approve it for a further two years, but with a cut in the total funding from borough councils from £1.2m a year to £1.08m. The report said that the cuts were needed because of national cuts to public health budgets.

    08 December 2016 | Public Sector Executive
  • UNAIDS: Young African women are especially vulnerable to HIV/AIDS

    The annual World AIDS Day report of the Joint United Nations Programme on HIV/AIDS (UNAIDS) offers a far more nuanced take on the epidemic than it has in previous years. For the first time, the report examines the disease in four age brackets that it calls “the life-cycle approach to HIV.” UNAIDS suggests this breakdown—0 to 14, 15 to 24, 25 to 49, and 50-plus—should lead to a clearer view of the epidemic’s “complex dynamics” and a more targeted response.

    23 November 2016 | Science
  • Community demand for temporary halt to Gilead DISCOVER study

    A group of U.S., Canadian, and European community advocates and HIV NGO workers have written a letter exrpesing "deep dismay" that Gilead Sciences have proceeded with the DISCOVER trial PrEP"without engaging stakeholders in a substantial or meaningful way.". DISCOVER will compared Gilead's new comination pill, Descovy against Truvada as PrEP. In 2007, the HIV/AIDS field adopted Good Participatory Practice (GPP), a formal set of guidelines approved by UNAIDS for stakeholder engagement in HIV prevention clinical trials. "It is astonishing," says the letter, "that Gilead has failed to follow GPP guidelines in the design and implementation of DISCOVER, since GPP was developed partly as a response to the failure of previous prevention trials involving tenofovir."

    17 November 2016 | HIV Prevention Justice Alliance
  • NHS England has power to fund Prep HIV drug, court decides

    The Court of Appeal has ruled that the NHS in England has the power to fund a drug which prevents HIV infection in people at high risk of the virus. NHS England had previously said that local authorities should provide the pre-exposure prophylaxis drug - known as Prep - because they are responsible for preventative health. But councils insisted they had too little money. An estimated 14,000 people would be eligible for Prep in England. NHS England said the judgment confirmed that it had the ability, but not the obligation, to fund Prep.

    10 November 2016 | BBC
  • PrEP for African migrants in Europe? A research agenda

    Clinical trials and demonstration projects in Europe have focused solely on men having sex with men (MSM). In contrast to global PrEP research, Europe seems to have overlooked heterosexuals at risk of HIV, mostly sub-Saharan African migrants and other ethnic minorities from endemic regions. Research should urgently investigate how to offer PrEP to all people in need: how to stimulate demand, how to deliver it, and how to support adherence.

    31 October 2016 | The Lancet HIV (requires free registration)
  • HIV Undetectable Does Equal Uninfectious: The Swiss Statement and the Vindication of Pietro Vernazza

    The Swiss Statement was a public policy salvo lobbed into the heart of the HIV world -- one that prompted a swift and intense backlash. People called it premature. People accused Vernazza of getting ahead of the science. Some demanded he produce data to prove there had been no transmissions. Others simply called him irresponsible. But it's not 2008 anymore.

    13 October 2016 | TheBody.com
  • HIVR4P Conference Ushers in 'Next-Gen' Prevention

    The next generation of biomedical HIV prevention will be a hot topic in Chicago at HIV Research for Prevention (HIVR4P) 2016.

    13 October 2016 | Medscape
  • How Do We Negotiate Condom Usage in the Age of PrEP?

    When I have anal sex, I usually use condoms, even after being on PrEP for two years. But I've interviewed scores of people on PrEP, mostly cis gay men, and the majority either never use condoms or only use them at a partner's request.

    29 September 2016 | The Body
  • The CDC’s Gay Dance Video about HIV is Flat Out Fabulous

    The Centers for Disease Control and Prevention (CDC) has produced a music video that joyfully educates gay men about HIV prevention options. And it is foot-stomping fabulous. See https://www.youtube.com/watch?v=_espkK-vLgc

    27 September 2016 | My Fabulous Disease
  • PrEP, test-and-treat offer most cost-effective methods for HIV prevention

    Pre-exposure prophylaxis, or PrEP, and “test-and-treat” methods are both more cost-effective than the current strategy for the prevention of HIV transmission among men who have sex with men, according to researchers. The success of either strategy, however, depends on treatment initiation and adherence.

    19 September 2016 | Healio
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.